Gilead’s thirdquarter earnings beat by a wide margin, and biotech raises guidance
Nov 06, 2024
Gilead Sciences Inc.’s stock rose 2.7% in after-hours trading Wednesday, after the biotech blew past third-quarter earnings estimates and raised its guidance, boosted by demand for its HIV and COVID-19 treatments.
https://www.marketwatch.com/story/gileads-third-quarter-earnings-beat-by-a-wide-margin-and-biotech-raises-guidance-77f53e7b?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service